Molecular identification of aminoglycosidemodifying enzymes among strains of Enterococcus spp. isolated in hospitals of the VIII Region of Chile;Identificación molecular de enzimas modificantes de aminoglucósidos en cepas de Enterococcus spp. aisladas en hospitales de la Octava Región de Chile

Revista Medica de Chile

Volumn 135, Issue 5, 2007, Pages 566-572

  Sepúlveda A, Marcela ^a   Bello T, Helia ^a   Domínguez Y, Mariana ^a   Mella M, Sergio ^a   Zemelman Z, Raúl ^b   González R, Gerardo ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Aminoglycosides; Drug resistance, microbial; Enterococcus

Indexed keywords

EID: 34347340674     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. SHEPARD BD, GILMORE MS. Antibiotic-resistant enterococci: the mechanisms and dynamic of drug introduction and resistance. Microbes Infect 2002; 4: 215-24.
2. LECLERCQ R. Enterococci acquire new kinds of resistance. Clin Infect Dis 1994; 24 (Suppl 1): 80-4.
3. MOELLERING R JR, WENNERSTEN C, MEDREK T, WEINBERG AN. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agentes Chemother 1970; 1: 335-40.
4. PATTERSON JE, ZERVOS MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990; 12: 644-52.
5. DAVIS BD. Bactericidal sinergism between ßlactams and aminoglycosides: mechanism and possible therapeutic implications. Rev Infect Dis 1982; 4: 237-45.
6. FERRETI JJ, GILMORE KS, COURVALIN P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 1986; 167: 631-8.
7. MCKAY GA, ROESTAMADJI J, MOBASHERY S, WRIGHT GD. Recognition of aminoglycoside antibiotics by enterococcal-staphylococcal aminoglycoside 3′-phosphotransferase type IIIa: Role of substrate amino groups. Antimicrob Agents Chemother 1996; 40: 2648-50.
8. CARLIER C, COURVALIN P. Emergence of 4′,4"-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother 1990; 34: 1565-9.
9. OUNISSI H, DERLOT E, CARLIER C, COURVALIN P. Gene homogeneity for aminoglycoside-modifying enzymes in Gram-positive cocci. Antimicrob Agents Chemother 1990; 34: 2164-8.
10. SEPÚLVEDA M, BELLO H, RUIZ M, HORMAZÁBAL J, DOMÍNGUEZ M, GONZÁ LEZ G ET AL. Metodología clásica y molecular en la identificación de especies de Enterococcus spp. Rev Méd Chile 2002; 130: 45-9.
11. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova. PA.
12. NATIONAL COMMITTE FOR CLINICAL LABORATORY STANDARDS. 1998. Performance Standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S8. National Committee for Clinical Laboratory Standards. Wayne, Pa.
13. SHAW KJ, SABATELLI FJ, NAPLES L, MANN P, HARE RS, MILLER HG. The application of molecular techniques for the study of aminoglycoside resistance. En Woodford, N. and Johnson, A.P, Eds. Methods in Molecular Medicine, Vol 15: Molecular Bacteriology: Protocols and Clinical Applications. Tatowa, New Jersey: Human Press Inc., 1998; 555-77.
14. SHAW KJ, HARE RS, SABATELLI FJ, RIZZO M, CRAMER CA, NAPLES L ET AL. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother 1991; 35: 2253-61.
15. SWENSON JM, FERRARO MJ, SHAM DF, CLARK NC, CULVER DH, TENOVER FC ET AL. Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol 1995; 33: 3008-18.
16. COQUE TM, ARDUINO RC, MURRAY BE. High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clin Infect Dis 1995; 20: 1048-51.
17. LEMAÎTRE N, SOUGAKOFF W, MASMOUDI A, FIEVET M-H, BISMUTH R, JARLIER V. Characterization of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus involved in nosocomial spread. J Clin Microbiol 1998; 36: 81-5.
18. LECLERQ R, DUTKA-MALEN S, BRISSON- NOEL A, MOLINAS C, DERLOT E, ARTHUR M ET AL. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 1992; 15: 495-501.
19. LOW DE, KELLER N, BARTH A, JONES RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): 133-45.
20. ELIOPOULOS GM, WENNERSTEN C, ZIGHELBOIM- DAUM S, REISZNER E, GOLDMANN D, MOELLERING RC JR. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988; 32: 1528-32.